» Articles » PMID: 17292338

CpG-induced IFNgamma Expands TLR4-specific IL-18 Responses in Vivo

Overview
Journal Cell Immunol
Publisher Elsevier
Date 2007 Feb 13
PMID 17292338
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Serum IL-18 responses to LPS increase after pretreatment with CpG-containing DNA. Compared to saline-pretreated controls, mice pretreated with CpG for two days produced 20-fold more serum IL-18 when challenged with lipopolysaccharide (LPS). In contrast, IFNgamma-deficiency or anti-IFNgamma pretreatment reduced CpG-expanded IL-18 responses to LPS by 67 and 83%, respectively. Mice pretreated with either IFNgamma or CpG comparably increased LPS-inducible serum IL-18 responses. LPS, compared to challenge with other TLR agonists, was best able to trigger high serum IL-18 levels in CpG-pretreated mice and this response was TLR4-dependent. CpG, compared to pretreatment with other TLR agonists, optimally expanded LPS-induced IL-18 responses that correlated with higher levels of circulating IFNgamma levels prior to LPS challenge. High-level serum IL-18 responses were caspase-1-dependent and P2X7 receptor-independent. We conclude that CpG promotes high-level IL-18 synthesis by an IFNgamma-dependent and IFNgamma-sufficient mechanism in vivo that is optimally triggered by LPS.

Citing Articles

Protective role of Cecropin AD against LPS-induced intestinal mucosal injury in chickens.

Zhi Y, Li T, Li Y, Zhang T, Du M, Zhang Q Front Immunol. 2024; 14:1290182.

PMID: 38162646 PMC: 10757607. DOI: 10.3389/fimmu.2023.1290182.


RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma.

Kahm Y, Kim I, Kim R Int J Mol Sci. 2023; 24(7).

PMID: 37047826 PMC: 10095367. DOI: 10.3390/ijms24076855.


TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T Cell differentiation.

Cui W, Joshi N, Liu Y, Meng H, Kleinstein S, Kaech S J Immunol. 2014; 192(9):4221-32.

PMID: 24659688 PMC: 4071140. DOI: 10.4049/jimmunol.1302569.


IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.

Yu Q, Vazquez R, Khojeini E, Patel C, Venkataramani R, Larson D Am J Physiol Heart Circ Physiol. 2009; 297(1):H76-85.

PMID: 19429811 PMC: 2711747. DOI: 10.1152/ajpheart.01285.2008.

References
1.
Perregaux D, McNiff P, LALIBERTE R, Conklyn M, Gabel C . ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol. 2000; 165(8):4615-23. DOI: 10.4049/jimmunol.165.8.4615. View

2.
Pien G, Satoskar A, Takeda K, Akira S, Biron C . Cutting edge: selective IL-18 requirements for induction of compartmental IFN-gamma responses during viral infection. J Immunol. 2000; 165(9):4787-91. DOI: 10.4049/jimmunol.165.9.4787. View

3.
SOLLE M, Labasi J, Perregaux D, Stam E, Petrushova N, Koller B . Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem. 2000; 276(1):125-32. DOI: 10.1074/jbc.M006781200. View

4.
Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O . Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta. J Immunol. 2001; 166(4):2651-7. DOI: 10.4049/jimmunol.166.4.2651. View

5.
Mehta V, Hart J, Wewers M . ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem. 2000; 276(6):3820-6. DOI: 10.1074/jbc.M006814200. View